Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium.

[1]  L. Hou,et al.  Surrogate tissue telomere length and cancer risk: shorter or longer? , 2012, Cancer letters.

[2]  Katarzyna Skonieczna,et al.  The landscape of mitochondrial DNA variation in human colorectal cancer on the background of phylogenetic knowledge. , 2012, Biochimica et biophysica acta.

[3]  Pui-Yan Kwok,et al.  Mitochondrial DNA sequence variation and risk of pancreatic cancer. , 2012, Cancer research.

[4]  Wen Tan,et al.  Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations , 2011, Nature Genetics.

[5]  B. Paulweber,et al.  Mitochondrial Haplogroups, Control Region Polymorphisms and Malignant Melanoma: A Study in Middle European Caucasians , 2011, PloS one.

[6]  V. Moreno,et al.  Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). , 2011, International journal of oncology.

[7]  J. Hoheisel,et al.  Pancreatic Cancer Susceptibility Loci and Their Role in Survival , 2011, PloS one.

[8]  E. Małecka-Panas,et al.  Role of cyclooxygenase-2 gene polymorphisms in pancreatic carcinogenesis. , 2011, World journal of gastroenterology.

[9]  Peter Kraft,et al.  Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. , 2011, Journal of the National Cancer Institute.

[10]  Suzanne Chambers,et al.  Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study , 2011, Nature Genetics.

[11]  Man Yu.  Generation, function and diagnostic value of mitochondrial DNA copy number alterations in human cancers. , 2011, Life sciences.

[12]  Hushan Yang,et al.  Association between mitochondrial DNA content in leukocytes and colorectal cancer risk , 2011, Cancer.

[13]  Stephen J. Chanock,et al.  Current status of genome-wide association studies in cancer , 2011, Human Genetics.

[14]  Mattias Johansson,et al.  Genetic Variability of the mTOR Pathway and Prostate Cancer Risk in the European Prospective Investigation on Cancer (EPIC) , 2011, PloS one.

[15]  Donghui Li,et al.  Association of multi‐drug resistance gene polymorphisms with pancreatic cancer outcome , 2011, Cancer.

[16]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[17]  Geoffrey S. Tobias,et al.  Family history of cancer and risk of pancreatic cancer: A pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan) , 2010, International journal of cancer.

[18]  Yusuke Nakamura,et al.  Genome-Wide Association Study of Pancreatic Cancer in Japanese Population , 2010, PloS one.

[19]  D. Wallace.  Bioenergetics and the epigenome: interface between the environment and genes in common diseases. , 2010, Developmental disabilities research reviews.

[20]  M. Ryska,et al.  Genotype and haplotype analysis of TP53 gene and the risk of pancreatic cancer: an association study in the Czech Republic. , 2010, Carcinogenesis.

[21]  Wei Zheng,et al.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 , 2010, Nature Genetics.

[22]  Geoffrey S. Tobias,et al.  Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer , 2009, Nature Genetics.

[23]  W. Foulkes,et al.  Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer. , 2009, Gastroenterology.

[24]  D. Silverman,et al.  Cancer of the Pancreas , 2009 .

[25]  Alison P. Klein,et al.  Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene , 2009, Science.

[26]  Q. Lan,et al.  Mitochondrial DNA content and lung cancer risk in Xuan Wei, China. , 2009, Lung cancer.

[27]  N. Rothman,et al.  A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma. , 2008, Blood.

[28]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[29]  Manal M. Hassan,et al.  Risk Factors for Pancreatic Cancer: Case-Control Study , 2007, The American Journal of Gastroenterology.

[30]  D. Wallace.  A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.

[31]  T. Key,et al.  EPIC–Oxford:lifestyle characteristics and nutrient intakes in a cohort of 33 883 meat-eaters and 31 546 non meat-eaters in the UK , 2003, Public Health Nutrition.

[32]  N. Day,et al.  EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.

[33]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[34]  K. Hess,et al.  DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer. , 2011, The oncologist.

[35]  C. Ambrosone,et al.  Mitochondrial copy number and risk of breast cancer: a pilot study. , 2010, Mitochondrion.